Newsroom
Sorted by: Latest
-
Apple’s Outstanding Comedy Widow’s Bay triumphs as the most decorated freshman comedy in Emmy history and Apple TV leads as the most awarded network at the 78th Primetime Emmy Awards
CULVER CITY, Calif.--(BUSINESS WIRE)--This evening at the 78th Primetime Emmy Awards, Apple TV shatters records to become the most awarded network of the year, landing 29 wins overall, including Outstanding Comedy Series for Widow’s Bay as the breakout sensation sweeps all major categories with 14 wins in total and cements itself as the most Emmy-awarded freshman comedy series in history. Additionally, Widow’s Bay lands the most wins for a comedy series in a single season, as well as the most p...
-
Powerful Medical Receives FDA De Novo Approval for PMcardio "Queen of Hearts," Its AI ECG Model for Detecting Acute Heart Attacks
NEW YORK--(BUSINESS WIRE)--Powerful Medical, a leader in AI-driven cardiovascular diagnostics, today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo authorization for Queen of Hearts (ACS AI ECG Model). The AI-powered model is designed to identify ECG findings suggestive of urgent acute coronary syndrome (ACS), which can include ST-segment elevation myocardial infarction (STEMI) and STEMI equivalents, and urgently notify clinicians of suspected cases. Heart attack...
-
UK Debt Management Office UK Regulatory Announcement: Issue of Debt
LONDON--(BUSINESS WIRE)-- DMO-TAS041/3728/002 The Minster Building21 Mincing LaneLondonEC3R 7AG T 020 7862 6500F 020 7862 6509www.dmo.gov.uk A122\26 15 September 2026 PRESS NOTICE RESULT OF THE SALE BY TENDER OF UP TO £1250 MILLION OF 0½% TREASURY GILT 2029The United Kingdom Debt Management Office ("DMO") announces that the tender of up to £1,250 million of 0½% Treasury Gilt 2029 (ISIN Code: GB00BLPK7227) has been allocated as follows:(Note: all prices in this notice ar...
-
ChatGPT Ads startet in Europa – Adform ist Technologieplattformpartner
HAMBURG, Deutschland--(BUSINESS WIRE)--Marken und Agenturen buchen ChatGPT Ads ab sofort über Adform und messen sie gemeinsam mit ihren übrigen Kampagnen...
-
Genexine’s GX-BP1 (SOX2 bioPROTAC) Suppresses Tumor Regrowth despite Osimertinib and Dato-DXd Combination and Achieves 6/6 Complete Responses in Triple Combination
SEOUL, South Korea--(BUSINESS WIRE)--Genexine, Inc. (KOSDAQ: 095700) announced that Jaehyun Choi, Ph.D., CEO and Head of R&D, presented new preclinical data for GX-BP1, the company’s SOX2-targeting bioPROTAC, at the 2026 World Conference on Lung Cancer (WCLC) in Seoul on September 13. The mini oral presentation, titled ‘Lung-Targeted mRNA-LNP Delivery of SOX2 bioPROTAC: A Comprehensive Strategy for LUAD, LUSC, and SCLC in Monotherapy and Combination Settings’ highlighted the potential of GX...
-
Samenvatting: Axo Longevity haalt een overtekende startkapitaalronde van $5M op om Europa’s toonaangevend lidmaatschap voor preventieve gezondheidszorg uit te bouwen
LONDEN & MADRID--(BUSINESS WIRE)--Axo Longevity kondigde vandaag de afsluiting aan van een overtekende startkapitaalronde van $5M om zijn lidmaatschap voor preventieve gezondheidszorg in heel Europa uit te breiden. De ronde werd gesteund door MS&AD Ventures, Izou Partners, LifeX Ventures, Everywhere Ventures, UNQ, 51 Ventures, Cistern Capital en NIAN Sports & Entertainment, samen met angel-investeerders waaronder Dr. Jorge Planas van Clinica Planas Barcelona en Daniel Kulle, voormalig v...
-
Axo Longevity lève 5 millions de dollars lors d’un cycle d’amorçage sursouscrit pour développer le premier programme d’adhésion en matière de santé préventive en Europe
LONDRES et MADRID--(BUSINESS WIRE)--Axo Longevity a annoncé aujourd’hui la clôture d’un cycle d’amorçage sursouscrit de 5 millions de dollars destiné à développer son programme d’adhésion en matière de santé préventive à travers l’Europe. Ce tour de table a été soutenu par MS&AD Ventures, Izou Partners, LifeX Ventures, Everywhere Ventures, UNQ, 51 Ventures, Cistern Capital et NIAN Sports & Entertainment, ainsi que par des investisseurs providentiels, notamment le Dr Jorge Planas de la C...
-
Axo Longevity Raises Oversubscribed $5M Seed Round to Build Europe’s Leading Preventive Health Membership
LONDON & MADRID--(BUSINESS WIRE)--Axo Longevity Raises Oversubscribed $5M Seed Round to Build Europe’s Leading Preventive Health Membership...
-
Resumen: Axo Longevity recauda 5 millones de dólares en una ronda de financiación inicial con exceso de demanda para crear el servicio de salud preventiva por suscripción líder en Europa
LONDRES Y MADRID--(BUSINESS WIRE)--Axo Longevity ha anunciado hoy el cierre de una ronda de financiación inicial de 5 millones de dólares, que ha tenido una demanda superior a la oferta, con el fin de ampliar su programa de salud preventiva para socios de toda Europa. La ronda contó con la participación de MS&AD Ventures, Izou Partners, LifeX Ventures, Everywhere Ventures, UNQ, 51 Ventures, Cistern Capital y NIAN Sports & Entertainment, junto con inversores ángeles como el Dr. Jorge Pla...
-
Axo Longevity schließt eine überzeichnete Startkapitalrunde in Höhe von 5 Millionen US-Dollar ab, um Europas führendes Mitgliedersystem für präventive Gesundheitsvorsorge aufzubauen
LONDON & MADRID--(BUSINESS WIRE)--Axo Longevity hat heute den Abschluss einer überzeichneten Startkapitalrunde in Höhe von 5 Millionen US-Dollar bekannt gegeben, um sein Mitgliedersystem für präventive Gesundheitsvorsorge in ganz Europa auszubauen. Die Finanzierungsrunde wurde von MS&AD Ventures, Izou Partners, LifeX Ventures, Everywhere Ventures, UNQ, 51 Ventures, Cistern Capital sowie NIAN Sports & Entertainment unterstützt, ebenso wie von Angel-Investoren, zu denen Dr. Jorge Planas v...